 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Protagonist Therapeutics Inc (PTGX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-06 Sale | 2019-08-08 6:15 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 10,792 | $8.8524 | $95,535 | 374,792 (Direct) | View |
| 2019-08-06 Sale | 2019-08-08 6:17 pm | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 3,395 | $8.8495 | $30,044 | 49,802 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:10 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 30,000 | $5.6167 | $168,500 | 409,824 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:11 pm | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 1,175 | $5.0952 | $5,987 | 1,175 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:32 pm | Protagonist Therapeutics Inc | PTGX | Gupta Suneel VP | 30,000 | $5.13 | $153,900 | 49,500 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:46 pm | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 8,000 | $5.7025 | $45,620 | 8,000 (Indirect Direct) | View |
| 2020-03-12 Purchase | 2020-03-12 7:26 pm | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 12,000 | $6.7 | $80,400 | 15,310 (Direct) | View |
| 2020-08-11 Sale | 2020-08-12 5:38 pm | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 2,499 | $17.19 | $42,952 | 0 (Direct) | View |
| 2021-01-19 Sale | 2021-01-20 8:20 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 24,846 | $24.6 | $611,105 | 426,144 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 6:36 pm | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 8,400 | $25.3 | $212,555 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-15 Option Award | 2019-05-16 6:43 pm | N/A 2029-05-14 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2019-05-31 Option Award | 2019-06-03 7:40 pm | N/A 2029-05-30 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:20 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:26 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:28 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:29 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:31 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:33 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Waddill William D. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-11-26 Exercise | 2019-11-27 2:58 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 4,000 | $1.16 | 379,824 (Direct) | View |
| 2019-11-26 Exercise | 2019-11-27 2:58 pm | N/A 2025-10-28 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 4,000 | $0 | 18,343 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:44 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:45 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:46 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:48 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 235,000 | $0 | 235,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:49 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 1:04 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 18,344 | $1.16 | 429,990 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 1:04 pm | N/A 2025-10-28 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 18,344 | $0 | 0 (Direct) | View |
| 2020-03-20 Exercise | 2020-03-23 6:14 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 10,000 | $1.89 | 439,990 (Direct) | View |
| 2020-03-20 Exercise | 2020-03-23 6:14 pm | N/A 2024-10-22 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 10,000 | $0 | 34,087 (Direct) | View |
| 2019-08-15 Option Award | 2020-04-08 5:46 pm | 2019-08-15 2029-08-14 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2020-04-29 Gift | 2020-05-01 5:32 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 2,000 | $0 | 437,990 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:12 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:15 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:16 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:18 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:19 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Waddill William D. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:21 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-08-11 Exercise | 2020-08-12 5:38 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 2,499 | $1.89 | 2,499 (Direct) | View |
| 2020-08-11 Exercise | 2020-08-12 5:38 pm | N/A 2024-10-22 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 2,499 | $0 | 7,499 (Direct) | View |
| 2020-08-17 Option Award | 2020-08-18 5:33 pm | N/A 2030-08-16 | Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 8:20 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 13,000 | $4.21 | 450,990 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 8:20 pm | N/A 2026-04-29 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 13,000 | $0 | 165,742 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 6:36 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 4,700 | $6.98 | 4,700 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 6:36 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 3,700 | $6.98 | 3,700 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:36 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 4,700 | $0 | 7,300 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:36 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 3,700 | $0 | 3,600 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:27 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 12,000 | $0 | 63,987 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:27 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:29 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 7,500 | $0 | 10,386 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:29 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:31 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 10,000 | $0 | 62,427 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:31 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:33 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 25,000 | $0 | 451,144 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:33 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 225,000 | $0 | 225,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:35 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer | 12,000 | $0 | 14,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:35 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer | 90,000 | $0 | 90,000 (Direct) | View |